Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
13 October 2022 | Story NONSINDISO QWABE | Photo Rio Button
The Lowveld serotine bat, named Neoromicia hlandzeni
The Lowveld serotine bat, named Neoromicia hlandzeni.

Biological expeditions to the unexplored central highlands of Angola between 2016 and 2019 led to the discovery of a new tiny, white-thumbed bat species from Eswatini by Prof Peter John Taylor from the UFS Department of Zoology and Entomology and the Afromontane Research Unit (ARU), together with colleagues from the University of Eswatini (UNESWA) and other collaborators.

The bat species, named Neoromicia hlandzeni or the Lowveld serotine bat – after the Lowveld of Eswatini (eHlandzeni) – is the first new animal species to be discovered in Eswatini and given a siSwati name. The Lowveld serotine bat is tiny at four grams, has a distinctive white thumb pad, and occurs in Eswatini, South Africa, Zimbabwe, and Mozambique.

Bats make up a quarter of all mammalian biodiversity. With modern technology and the exploration of previously inaccessible regions of Africa, the rate of discovery of both animal and plant species is accelerating.

According to Prof Taylor, the Lowveld serotine bat is a new species to science. The specimen from which the species was named was collected in the lowlands of Eswatini in 2005. “Later collections of bats from the highlands of Angola, undertaken by myself and students, revealed the fact that the highland and lowland forms were actually different species. Since there was already a name for the highland bat, we needed to find a new name for the lowland bat from Eswatini and South Africa, hence it is called the Lowveld serotine bat,” he said.

The importance of integrative taxonomy, local collaboration, and biodiversity surveys

Prof Taylor is a research fellow of the National Geographic Okavango Wilderness Project, and the bat discovery took place during expeditions under the patronage of the Angolan government, the Wild Bird Trust, and the National Geographic Okavango Wilderness Project. He said the aim of the expedition was to explore the plants and animals of a wilderness area (the source of the Okavango) that had not been explored before.

The discovery also led to their paper being published in the scientific journal, the Zoological Journal of the Linnean Society, this month. 

The publication, titled Integrative taxonomic analysis of new collections from the central Angolan highlands resolves the taxonomy of African pipistrelloid bats on a continental scale, showcases the importance of integrative taxonomy, local collaboration, and biodiversity surveys, as the description of this exciting new species would not have been possible without comparative genetic and morphological material from new collections in the poorly sampled central highlands of Angola. 
Prof Peter Taylor with his students, Veli Mdluli and Alexandra Howard
Prof Peter Taylor with his students, Veli Mdluli and Alexandra Howard, working on bat research. Howard was one of the co-authors of the paper. (Photo: Supplied)

Afromontane regions as hotspots of bat speciation, diversity, and micro-endemism

Although Prof Taylor is the first author to describe this new species, the work was done with a multidisciplinary team of colleagues, students, and collaborators from the UFS, UNESWA, the University of Pretoria, the University of Venda, and Stellenbosch University, as well as the Durban Natural Science Museum and the Ditsong National Museum of Natural History, with support from the Angolan government, the Wild Bird Trust, and the National Geographic Okavango Wilderness Project. 
“Describing a new species is an arduous task that can take years from discovery to publication. All the enormous collective efforts have shown the importance of collaborative biodiversity exploration using old and modern technologies, as well as the African ownership of this discovery,” Prof Taylor said.

Three of Prof Taylor's previous and current PhD students – all of them South African women – were part of this discovery process and are co-authors of the paper. All 14 co-authors in the team are African. Prof Taylor said the discovery adds a new species to the total bat list of 125 species for Southern Africa – at number 126.

News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept